Serum levels of soluble Fas antigen in chronic hepatitis C patients
Authors:
- Norio HayashiNHNorio Hayashi
- Eiji MitaEMEiji Mita
- Keiji UedaKUKeiji Ueda
- Kiyoshi MochizukiKMKiyoshi Mochizuki
- Naoki HiramatsuNHNaoki Hiramatsu
- Kanto TatsuyaKTKanto Tatsuya
- Yutaka SasakiYSYutaka Sasaki
- Masatsugu HoriMHMasatsugu Hori
- 1 October 1998
- journal article
- Published by Elsevier in Journal of Hepatology
- Vol. 29 (4) , 517-523
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology
This publication has 30 references indexed in Scilit:
- Fas antigen expression in liver tissues of patients with chronic hepatitis BJournal of Hepatology, 1996
- Involvement of the CD95 (APO-1/Fas) receptor and ligand in liver damage.Journal of Experimental Medicine, 1995
- Cytolytic T-cell cytotoxicity is mediated through perforin and Fas lytic pathwaysNature, 1994
- Fas and Perforin Pathways as Major Mechanisms of T Cell-Mediated CytotoxicityScience, 1994
- Immunohistochemical detection of Fas antigen in liver tissue of patients with chronic hepatitis CHepatology, 1994
- Protection from Fas-Mediated Apoptosis by a Soluble Form of the Fas MoleculeScience, 1994
- Circulating intercellular adhesion molecule-1 (ICAM-1) in autoimmune liver disease and evidence for the production of ICAM-1 by cytokine-stimulated human hepatocytesClinical and Experimental Immunology, 1994
- Molecular cloning and expression of the fas ligand, a novel member of the tumor necrosis factor familyCell, 1993
- Effects of interferon on intrahepatic human leukocyte antigens and lymphocyte subsets in patients with chronic hepatitis B and CHepatology, 1991
- Detection of Antibody to Hepatitis C Virus in Prospectively Followed Transfusion Recipients with Acute and Chronic Non-A, Non-B HepatitisNew England Journal of Medicine, 1989